BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of 4-amino-quinolines as antitumor agents. 2022

Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
College of Pharmaceutical and Biological Engineering, Shenyang University of Chemical Technology, Shenyang, China.

Fifteen novel 4-amino-quinolines (I1-III3) as antitumor agent were synthesized by p-nitroaniline and ethoxymethylene malonic ester (EMME) via condensation, cyclization, hydrolysis, decarboxylation, chlorination, nucleophilic substitution, reduction and amidation. The antitumor activity of compounds I1-III3 was evaluated on SGC-7901, BEL-7402 and A549 cancer cell lines. In vitro bioassay indicated that some compounds showed different degree activity against all tested cancer cell lines. Compound I1, I4 and II2 exhibited high effects against A549 cell lines (IC50 = 1.34μM, 1.36μM and 3.00μM, respectively). In addition, the result of molecular docking showed that compound I1, I4 and II2 could dock into the pocket of EGFR.

UI MeSH Term Description Entries
D011804 Quinolines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072283 A549 Cells An immortalized cell line derived from human ADENOCARCINOMA, ALVEOLAR basal epithelial cells isolated from the lungs of a male patient in 1972. The cell line is positive for KERATIN, can synthesize LECITHIN, and contains high levels of POLYUNSATURATED FATTY ACIDS in its PLASMA MEMBRANE. It is used as a model for PULMONARY ALVEOLI function and virus infections, as a TRANSFECTION host, and for PRECLINICAL DRUG EVALUATION. A549 Cell Line,A549 Cell,A549 Cell Lines,Cell Line, A549,Cell Lines, A549,Cell, A549,Cells, A549
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014528 Uricosuric Agents Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. Uricosuric Agent,Agent, Uricosuric,Agents, Uricosuric
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
Design, synthesis and biological evaluation of 4-(4-aminophenoxy)picolinamide derivatives as potential antitumor agents.
September 2023, European journal of medicinal chemistry,
Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
September 2018, Molecules (Basel, Switzerland),
Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
Design, synthesis, and biological evaluation of novel 4-phenoxypyridine derivatives as potential antitumor agents.
May 2019, Archiv der Pharmazie,
Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
Synthesis and biological evaluation of new 2‑substituted‑4‑amino-quinolines and -quinazoline as potential antifungal agents.
September 2022, Bioorganic & medicinal chemistry letters,
Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
November 2013, European journal of medicinal chemistry,
Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
Design, synthesis and biological evaluation of pazopanib derivatives as antitumor agents.
March 2014, Chemical biology & drug design,
Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives.
October 2004, Journal of medicinal chemistry,
Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
Antitumor agents. Part 202: novel 2'-amino chalcones: design, synthesis and biological evaluation.
April 2000, Bioorganic & medicinal chemistry letters,
Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
February 2017, Bioorganic & medicinal chemistry letters,
Dan Liu, and Aiqi Xue, and Haifeng Wang, and Tian Luan, and Xue Li
Design, synthesis, and biological evaluation of 3',4',5'-trimethoxy evodiamine derivatives as potential antitumor agents.
November 2021, Drug development research,
Copied contents to your clipboard!